Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

BETAXOLOL HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Betaxolol Hydrochloride, and when can generics launch?

Betaxolol Hydrochloride is a drug marketed by Teligent Pharma Inc, Epic Pharma, Apotex Inc, Kvk Tech, Akorn, and Wockhardt. and is included in six NDAs.

The generic ingredient in BETAXOLOL HYDROCHLORIDE is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.

Summary for Tradename: BETAXOLOL HYDROCHLORIDE

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list7
Bulk Api Vendors: see list53
Clinical Trials: see list988
Patent Applications: see list1,206
Drug Prices:see details
DailyMed Link:BETAXOLOL HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: BETAXOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent Pharma Inc
BETAXOLOL HYDROCHLORIDE
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC075630-001Apr 12, 2001ATRXNoNo► Subscribe► Subscribe
Akorn
BETAXOLOL HYDROCHLORIDE
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC075386-001Jun 30, 2000ATRXNoNo► Subscribe► Subscribe
Apotex Inc
BETAXOLOL HYDROCHLORIDE
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC075446-001Sep 28, 2000DISCNNoNo► Subscribe► Subscribe
Wockhardt
BETAXOLOL HYDROCHLORIDE
betaxolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC078694-001Nov 16, 2009ATRXNoNo► Subscribe► Subscribe
Epic Pharma
BETAXOLOL HYDROCHLORIDE
betaxolol hydrochloride
TABLET;ORAL075541-001Oct 22, 1999ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot